Preclinical characterization of human Kallikrein 2 (hK2) as a novel target for the treatment of prostate cancer Meeting Abstract
| Authors: | Shen, F.; Kelly, W. K.; Pandit-Taskar, N.; McDevitt, T.; Smith, R.; Menard, K.; Packman, K.; Chaudhary, R.; Rupnow, B.; Yu, M. K.; Guckert, M. E.; Tian, S. K.; Chu, G.; Xie, H.; Patricia, D.; Max, S. I.; Morris, M. J. |
| Abstract Title: | Preclinical characterization of human Kallikrein 2 (hK2) as a novel target for the treatment of prostate cancer |
| Meeting Title: | 2024 ASCO Genitourinary Cancers Symposium |
| Keywords: | 613-213-2711-3371; 261-492-3532-9726; 283-183-180-5577-2829-12292; 283-183-180; 613-615-646-2680-2603; 613-4678-146-9287; 130-540-543 |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2024 Jan 25-27 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-02-01 |
| Language: | English |
| ACCESSION: | WOS:001266676900432 |
| DOI: | 10.1200/JCO.2024.42.4_suppl.202 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 202 -- Source: Wos |
